Xian Liang Li Selected Research

Reperfusion Injury

1/2005	FTY720 attenuates hepatic ischemia-reperfusion injury in normal and cirrhotic livers.
9/2004	Insulin in UW solution exacerbates hepatic ischemia / reperfusion injury by energy depletion through the IRS-2 / SREBP-1c pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xian Liang Li Research Topics

Disease

2	Reperfusion Injury 01/2005 - 09/2004
1	Ischemia 01/2005
1	Portal Hypertension 07/2004

Drug/Important Bio-Agent (IBA)

1	Fingolimod Hydrochloride (FTY720)FDA Link 01/2005
1	Sterol Regulatory Element Binding Protein 1IBA 09/2004
1	Insulin (Novolin)FDA Link 09/2004
1	University of Wisconsin-lactobionate solutionIBA 09/2004
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 07/2004
1	FK 409IBA 07/2004

Therapy/Procedure

1	Liver Transplantation 07/2004